HomeLatest NewsDr. Reddy's asked to submit revised protocol for Sputnik V vaccine trials

Dr. Reddy’s asked to submit revised protocol for Sputnik V vaccine trials

@the_news_21

According to sources, an expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr. Reddy’s Laboratories to submit a revised protocol for conducting phase-2 and phase-3 human clinical trials in India for the Russian Covid-19 vaccine, Sputnik V.

The Hyderabad-based pharmaceutical company had applied to the Drugs Controller General of India (DCGI) last week, seeking permission to conduct phase-3 human clinical trials of the Russian vaccine. The Subject Expert Committee (SEC) on Covid-19 at CDSCO, asked the firm to submit a revised protocol stating it will have to conduct phase 2 and phase 3 clinical trials in a combined manner, sources told PTI. “It means that Dr. Reddy’s laboratories will have to submit a new application. According to the SEC, they have to conduct both phase-2 and phase-3 clinical trials and cannot directly hold phase-3 trial for the vaccine in India,” a source said.

Also Read: COVID-19 vaccine rollout unlikely before fall 2021, say experts

The Indian pharma giant has collaborated with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V vaccine for Covid-19. Upon regulatory approval in India, RDIF shall supply Dr. Reddy’s with, 100 million doses of the vaccine, the firm had announced last month. Meanwhile, phase-3 trials of Sputnik V are currently underway in Russia since September 1 on 40,000 subjects. Sputnik V has been jointly developed by the Gamaleya National Research Center of Epidemiology and Microbiology and RDIF.

Currently two indigenously developed vaccine candidates for Covid-19, one by Bharat Biotech in collaboration with ICMR and another one by Zydus Cadila Ltd, are undergoing phase 2 of human clinical trials. Pune-based Serum Institute of India, which has partnered with AstraZeneca for manufacturing the Oxford Covid-19 vaccine is also conducting phase 2 and phase 3 human clinical trials in India.

Subscribe to TheNews21

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

41 COMMENTS

  1. Connect the millions winning big on fanduel casino New Jersey – the #1 tangible in dough casino app in America.
    Respite c start your $1000 WITH IT AGAIN gratuity and refashion every spin, hand and rolling into bona fide readies rewards.
    Irresponsibly payouts, whopping jackpots, and day in action – download FanDuel Casino now and start playing like a pro today!

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img

@the_news_21

According to sources, an expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr. Reddy’s Laboratories to submit a revised protocol for conducting phase-2 and phase-3 human clinical trials in India for the Russian Covid-19 vaccine, Sputnik V.

The Hyderabad-based pharmaceutical company had applied to the Drugs Controller General of India (DCGI) last week, seeking permission to conduct phase-3 human clinical trials of the Russian vaccine. The Subject Expert Committee (SEC) on Covid-19 at CDSCO, asked the firm to submit a revised protocol stating it will have to conduct phase 2 and phase 3 clinical trials in a combined manner, sources told PTI. “It means that Dr. Reddy’s laboratories will have to submit a new application. According to the SEC, they have to conduct both phase-2 and phase-3 clinical trials and cannot directly hold phase-3 trial for the vaccine in India,” a source said.

Also Read: COVID-19 vaccine rollout unlikely before fall 2021, say experts

The Indian pharma giant has collaborated with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V vaccine for Covid-19. Upon regulatory approval in India, RDIF shall supply Dr. Reddy’s with, 100 million doses of the vaccine, the firm had announced last month. Meanwhile, phase-3 trials of Sputnik V are currently underway in Russia since September 1 on 40,000 subjects. Sputnik V has been jointly developed by the Gamaleya National Research Center of Epidemiology and Microbiology and RDIF.

Currently two indigenously developed vaccine candidates for Covid-19, one by Bharat Biotech in collaboration with ICMR and another one by Zydus Cadila Ltd, are undergoing phase 2 of human clinical trials. Pune-based Serum Institute of India, which has partnered with AstraZeneca for manufacturing the Oxford Covid-19 vaccine is also conducting phase 2 and phase 3 human clinical trials in India.

Html code here! Replace this with any non empty text and that's it.

41 COMMENTS

  1. Connect the millions winning big on fanduel casino New Jersey – the #1 tangible in dough casino app in America.
    Respite c start your $1000 WITH IT AGAIN gratuity and refashion every spin, hand and rolling into bona fide readies rewards.
    Irresponsibly payouts, whopping jackpots, and day in action – download FanDuel Casino now and start playing like a pro today!

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img